SEARCH

SEARCH BY CITATION

Table S1. Prohibited treatments and duration of washout

Table S2. Investigator’s GlobalAssessment (IGA) rating scale for overall psoriatic disease

Table S3. Patients receiving secukinumab injections and relapse rate during maintenance period

Table S4. Adverse events leading to permanent discontinuation of study drug by primary system organ class and preferred term, by induction treatment

Table S5. Adverse events leading to permanent discontinuation of study drug by primary system organ class and preferred term, by maintenance treatment.

FilenameFormatSizeDescription
bjd12112_sm_TableS1-S5-FigS1.doc108KSupporting info item

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.